Skip to main content
锦波生物 logo

锦波生物 — Investor Relations & Filings

Ticker · 920982 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 391 across all filing types
Latest filing 2025-09-17 Notice of Dividend Amou…
Country CN China
Listing Beijing Stock Exchange 920982

About 锦波生物

https://www.sxjbswyy.com/

Shanxi Jinbo Bio-Pharmaceutical Co., Ltd. specializes in the research, development, and manufacturing of functional proteins through synthetic biology. The company is recognized for its industrialization of recombinant humanized collagen, specifically Type III collagen with a stable triple helix structure. Its core business encompasses the production of medical-grade biomaterials, functional skincare products, and medical devices used in aesthetics, wound healing, and gynecological health. By utilizing advanced protein engineering, the company provides biocompatible solutions designed for tissue repair and anti-aging applications. Its technical focus remains on the structural optimization and large-scale production of high-purity recombinant proteins to meet clinical and consumer health demands.

Recent filings

Filing Released Lang Actions
2025年半年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is titled as an announcement regarding the implementation of the 2025 half-year equity distribution plan by Shanxi Jinbo Biopharmaceutical Co., Ltd. It details the dividend distribution scheme, tax deductions, record date, ex-dividend date, and the method of dividend payment. It also references a shareholders' meeting resolution approving the plan. The document length is short (1386 characters) and it primarily announces the dividend distribution details rather than providing a full financial report or detailed analysis. This fits the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and details for shareholders.
2025-09-17 Chinese
关于完成工商变更登记及公司章程备案的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the completion of industrial and commercial registration changes and the filing of the company's articles of association. It references previous announcements about board and senior management changes and company charter amendments. The document is short (709 characters) and serves as a formal notice of completed administrative changes rather than a detailed report or financial statement. It does not contain financial data or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-09-17 Chinese
关于公司股东协议转让股份完成过户登记的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the completion of a shareholder agreement transfer of shares, including details about the transfer agreement, the number of shares transferred, the transfer price, and the updated shareholding structure. It also references a confirmation letter from the securities registration and settlement company. The document does not contain financial statements or detailed financial performance data. It is a regulatory announcement about a change in share ownership but does not indicate a major shareholding notification crossing thresholds, nor is it a report or presentation. This fits best under Regulatory Filings (RNS) as a general regulatory announcement about share transfer completion.
2025-09-14 Chinese
第四届董事会第十六次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of the resolutions passed at the 16th meeting of the 4th Board of Directors of Shanxi Jinbo Biopharmaceutical Co., Ltd. It details the meeting date, attendance, and the approval of a proposal to replace a member of the audit committee due to a change in position. The content focuses on board-level decisions and changes in committee membership, with no financial data or report attached. This fits the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2025-09-10 Chinese
关于补选第四届董事会审计委员会委员的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the replacement of a member of the company's board audit committee. It details the election of a new audit committee member due to the previous member becoming the general manager, which disqualifies her from the committee. The document references the company's board meeting and governance rules but does not contain financial data, audit results, or detailed management reports. It is clearly about a change in board committee membership, which falls under Board/Management Information (MANG). The document length is short and focused on governance changes, not a full report or announcement of voting results. Therefore, the appropriate classification is MANG with high confidence.
2025-09-10 Chinese
2025年第四次临时股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2025 fourth extraordinary shareholders meeting of Shanxi Jinbo Biopharmaceutical Co., Ltd. It includes information about the meeting date, attendance, voting results on various proposals, and legal opinions confirming the validity of the meeting and its resolutions. The content focuses on the voting outcomes and procedural details of the shareholders meeting rather than presenting financial data or management discussion. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is under 5,000 characters but contains substantive voting results, so it is not merely a report publication announcement. Therefore, the correct classification is DVA with high confidence.
2025-09-07 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.